Restoring Cognitive Functions, Regenerating the Brain

ExQor is developing a unique biologic.

ExQor's biologic would restore cognitive capabilities by regenerating neurons and their connections that were damaged by disease.

ExQor's biologic would treat learning and memory issues quicker and better and with less side effects than existing treatment methods.

Treatments for multiple CNS disorders are possible using ExQor's biologic as well as for treating depression and obesity.

ExQor has shown preclinical success in restoring cognitive functioning in Alzheimer's, HIV associated dementias, and recovery from addictions like methamphetamine addiction.

ExQor is preparing its first IND application to FDA for treating cognitive impairments that are consequences of Alzheimer’s disease.

ExQor applications to FDA for treating additional CNS disorders with its biologic would follow.

MRI Detection of Very Early Stage Alzheimer's

A valley of uncertainty exists among those diagnosed with MCI or early AD or who have family members or relations who have or had AD and are concerned whether they are also at risk of AD.

ExQor has MRI diagnostic development programs for detecting and assessing very early-stage Alzheimer's or identifying mild cognitive impairment (MCI) that could convert to Alzheimer's.

Via ExQor providing new MRI tools for early AD detection more accessible healthcare for AD patients could become possible.

The new MRI tool is specific to regions of brain impacted by early AD (notably, hippocampus.) ExQor's AD diagnostic tool would provide conventional MRI with high sensitivity for receptor imaging that is similar to PET, which is not available in most clinics.

Concurrent use of ExQor's biologic at the point of early MRI detection could treat and mitigate progression of Alzheimer's.

Strong AI Background

Because ExQor's founders' also have extensive experience in developing AI systems.

ExQor is developing a unique AI system for detecting and treating neurodegenerative disorders.

Some ExQor AI goals are precision dosing, improved maintenance and patient compliance, and personalized treatment with ExQor's biologic.

ExQor also could apply its AI knowhow to its molecular level MRI diagnostic agents for improved and/or preventive Alzheimer's treatments using ExQor's biologic.

ExQor has multiple allowed patents and patents pending.